Heat Biologics has been granted a 180-day extension by NASDAQ to meet the requirements for continued listing on its exchange.
Heat Biologics (NASDAQ:HTBX) has been granted a 180-day extension by NASDAQ to meet the requirements for continued listing on its exchange.
As quoted in the press release:
As previously reported, Heat received notice from NASDAQ on March 15, 2017, that it was not in compliance with the minimum bid price requirements of $1 for 30 consecutive business days. Per NASDAQ rules, Heat was afforded 180 calendar days, or until September 11, 2017, to regain compliance. NASDAQ has determined that the Company is eligible for an additional 180 calendar days to regain compliance. If at any time during the second 180-day period the closing bid price of Heat’s common stock is at least $1 per share, for a minimum of 10 consecutive business days, NASDAQ will provide written confirmation of compliance and this matter will be closed.